TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Avia Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
20,248
|
19,523
|
19,383 |
Financial expenses |
3,499
|
2,736
|
155 |
Earnings before taxes |
-893
|
1,715
|
1,690 |
EBITDA |
1,136
|
2,785
|
2,010 |
Total assets |
44,878
|
45,210
|
10,199 |
Current assets |
10,230
|
11,227
|
6,111 |
Current liabilities |
4,466
|
5,362
|
4,250 |
Equity capital |
7,934
|
6,153
|
2,872 |
- share capital |
27
![]() |
27
|
29 |
Employees (average) |
8
|
7
|
6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
17.7%
|
13.6%
|
28.2% |
Turnover per employee |
2,531
|
2,789
|
3,230 |
Profit as a percentage of turnover |
-4.4%
|
8.8%
|
8.7% |
Return on assets (ROA) |
5.8%
|
9.8%
|
18.1% |
Current ratio |
229.1%
|
209.4%
|
143.8% |
Return on equity (ROE) |
-11.3%
|
27.9%
|
58.8% |
Change turnover |
668
|
1,710
|
271 |
Change turnover % |
3%
|
10%
|
1% |
Chg. No. of employees |
1
![]() |
1
![]() |
1 |
Chg. No. of employees % |
14%
|
17%
|
20% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.